Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Giunti Psychometrics Holding SpA Debt-to-Equity?
Giunti Psychometrics Holding SpAMIL:GPSY -0.67%13 Debt-to-Equity is 1.57 as of Dec. 2025, which is 11% above its 10-year median of 1.42. GuruFocus rates MIL:GPSY with a GF Score™ of 13/100. Among 696 Medical Devices & Instruments companies, Giunti Psychometrics Holding SpA ranks worse than 92.82% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for Giunti Psychometrics Holding SpA's Debt-to-Equity or its related term are showing as below:
MIL:GPSY'
s Debt-to-Equity Range Over the Past 10 Years
Min: 1.27 Med: 1.42 Max: 1.57
Current: 1.57
During the past 2 years, the highest Debt-to-Equity Ratio of Giunti Psychometrics Holding SpA was 1.57. The lowest was 1.27. And the median was 1.42.
MIL:GPSY's Debt-to-Equity is ranked worse than 92.82% of 696
companies
in the Medical Devices & Instruments industry
Industry Median: 0.24
vs MIL:GPSY: 1.57
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
Giunti Psychometrics Holding SpA Debt-to-Equity Related Terms
Giunti Psychometrics Holding SpA Debt-to-Equity Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MIL:GPSY vs ABT, SYK, MDT: Debt-to-Equity Comparison
For the Medical Devices subindustry, Giunti Psychometrics Holding SpA's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Giunti Psychometrics Holding SpA Debt-to-Equity vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Giunti Psychometrics Holding SpA's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where Giunti Psychometrics Holding SpA's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Giunti Psychometrics Holding SpA (MIL:GPSY) has a Debt-to-Equity of 1.57 as of Dec. 2025. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Giunti Psychometrics Holding SpA and its competitors. This is 11% above median its historical median of 1.42. Over the past decade, Giunti Psychometrics Holding SpA's Debt-to-Equity has ranged from 1.27 to 1.57. According to the industry distribution chart, Giunti Psychometrics Holding SpA ranks #646 out of 696 companies in the Medical Devices & Instruments industry, placing it in the top 92.8%.
Is Giunti Psychometrics Holding SpA's Debt-to-Equity too high?
Giunti Psychometrics Holding SpA's current Debt-to-Equity of 1.57 is 11% above median its 10-year median of 1.42. Over the past 10 years, this metric has ranged from a low of 1.27 to a high of 1.57. The Medical Devices & Instruments industry median Debt-to-Equity is 0.24. Giunti Psychometrics Holding SpA's value of 1.57 is 554.2% above this industry median. Based on the distribution chart, Giunti Psychometrics Holding SpA ranks #646 out of 696 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Giunti Psychometrics Holding SpA has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does Giunti Psychometrics Holding SpA's Debt-to-Equity compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Giunti Psychometrics Holding SpA ranks #646 out of 696 companies for Debt-to-Equity. This places Giunti Psychometrics Holding SpA in the lower half of its industry. The industry median Debt-to-Equity is 0.24. Giunti Psychometrics Holding SpA's value of 1.57 is 554.2% above this benchmark. Historically, Giunti Psychometrics Holding SpA's own Debt-to-Equity has ranged from 1.27 to 1.57 over the past decade. While the company's 10-year median is 1.42 vs. the industry median of 0.24, Giunti Psychometrics Holding SpA has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Medical Devices & Instruments company?
The median Debt-to-Equity among Medical Devices & Instruments companies is 0.24, based on 696 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Giunti Psychometrics Holding SpA's current Debt-to-Equity of 1.57 is 554.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Giunti Psychometrics Holding SpA and its competitors. For the Medical Devices & Instruments industry, the median Debt-to-Equity is 0.24 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Giunti Psychometrics Holding SpA's current Debt-to-Equity is 1.57, which is 11% above median its own 10-year median of 1.42. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Giunti Psychometrics Holding SpA stock overvalued right now?
Giunti Psychometrics Holding SpA (MIL:GPSY) has a current Debt-to-Equity of 1.57. The current Debt-to-Equity is 1.57, which is 11% above median its 10-year median of 1.42 and 554.2% above the Medical Devices & Instruments industry median of 0.24. Giunti Psychometrics Holding SpA's overall GF Score™ is 13/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For Giunti Psychometrics Holding SpA (MIL:GPSY), the current Debt-to-Equity is 1.57 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Giunti Psychometrics Holding SpA operates internationally in the field of psychological assessment. The company designs, develops, and distributes tools and methodologies for psychologicaland psycho-aptitude assessment, used in various fields, including clinical practice (clinical and health psychology, child psychiatry and neuropsychiatry, neuropsychology and speech therapy), human resources management (work and organizational psychology), and education and guidance (level assessment tests, tools for diagnosing learning difficulties, and tools for school, university, and career guidance). The majority of revenue is derived from sales in the mental health and clinical area.
13GF Score
Get the complete analysis for MIL:GPSY
Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MIL:GPSY has been successfully added to your 
